2022 Senate Bill 1170

Revise opioid antagonist regulation detail

Introduced in the Senate

Sept. 20, 2022

Introduced by Sen. Curtis VanderWall (R-35)

To slightly broaden the authority of government agencies to distribute the opioid antagonist drug “naloxone;” see Senate Bill 1171.

Referred to the Committee on Health Policy and Human Services

Nov. 29, 2022

Reported without amendment

With the recommendation that the bill pass.